Although early diagnosis allows the opportunity for curative surgery, around 35% of men who have undergone radical prostatectomy have prostate-specific antigen (PSA) recurrence within 10 years after the operation and it is often a result of micrometastatic disease occurring at the time of surgery [2–5]. The gene discussed is KLK3; the disease is glycogen storage disease VI.